Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder

A retrospective study of patients treated using radical cystectomy

Nilda Gonzalez-Roibon, Jenny J. Kim, Sheila F. Faraj, Alcides Chaux, Stephania M. Bezerra, Enrico Munari, Carla Ellis, Rajni Sharma, Daniel Keizman, Trinity J. Bivalacqua, Mark P. Schoenberg, Mario Eisenberger, Michael Carducci, George J. Netto

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective To assess the insulin-like growth factor-1 receptor (IGF1R) expression in urothelial carcinoma (UC) and its prognostic role in relation to clinicopathologic parameters. Methods A total of 100 cases of invasive UC were evaluated using tissue microarrays. Membranous IGF1R staining was evaluated using immunohistochemistry. A scoring method analogous to that of HER2 expression in breast carcinoma was used, and the highest score was assigned in each tumor. IGF1R was considered overexpressed in cases with score ≥1. Results We found IGF1R overexpression in 62% of invasive UC. IGF1R overexpression was associated with race (P =.04) and pT category (P =.03). Median follow-up was 29 months (range, 0.5-212). Progression rate was 60%, and overall mortality and cancer-specific mortality rates were 69% and 51%, respectively. In invasive UC, IGF1R overexpression was significantly associated with overall mortality and cancer-specific mortality (Mantel Cox P =.0002 and P =.006, respectively). IGF1R overexpression was associated with increased hazard ratios (HRs) for overall mortality (HR = 2.63, P =.001) and cancer-specific mortality (HR = 2.45, P =.01), independently and after adjusting for clinicopathologic features and treatment modalities. Conclusion We found IGF1R overexpression in 62% of bladder UC. More importantly, IGF1R overexpression was a significant predictor of overall mortality and cancer-specific mortality, suggesting its potential role as a prognosticator in UC of bladder.

Original languageEnglish (US)
JournalUrology
Volume83
Issue number6
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Somatomedin Receptors
Cystectomy
Urinary Bladder
Retrospective Studies
Carcinoma
Mortality
Neoplasms
Research Design
Immunohistochemistry
Staining and Labeling
Breast Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder : A retrospective study of patients treated using radical cystectomy. / Gonzalez-Roibon, Nilda; Kim, Jenny J.; Faraj, Sheila F.; Chaux, Alcides; Bezerra, Stephania M.; Munari, Enrico; Ellis, Carla; Sharma, Rajni; Keizman, Daniel; Bivalacqua, Trinity J.; Schoenberg, Mark P.; Eisenberger, Mario; Carducci, Michael; Netto, George J.

In: Urology, Vol. 83, No. 6, 2014.

Research output: Contribution to journalArticle

Gonzalez-Roibon, N, Kim, JJ, Faraj, SF, Chaux, A, Bezerra, SM, Munari, E, Ellis, C, Sharma, R, Keizman, D, Bivalacqua, TJ, Schoenberg, MP, Eisenberger, M, Carducci, M & Netto, GJ 2014, 'Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: A retrospective study of patients treated using radical cystectomy', Urology, vol. 83, no. 6. https://doi.org/10.1016/j.urology.2014.01.028
Gonzalez-Roibon, Nilda ; Kim, Jenny J. ; Faraj, Sheila F. ; Chaux, Alcides ; Bezerra, Stephania M. ; Munari, Enrico ; Ellis, Carla ; Sharma, Rajni ; Keizman, Daniel ; Bivalacqua, Trinity J. ; Schoenberg, Mark P. ; Eisenberger, Mario ; Carducci, Michael ; Netto, George J. / Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder : A retrospective study of patients treated using radical cystectomy. In: Urology. 2014 ; Vol. 83, No. 6.
@article{332764e14b1243539b7c29d8a8f58ff1,
title = "Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: A retrospective study of patients treated using radical cystectomy",
abstract = "Objective To assess the insulin-like growth factor-1 receptor (IGF1R) expression in urothelial carcinoma (UC) and its prognostic role in relation to clinicopathologic parameters. Methods A total of 100 cases of invasive UC were evaluated using tissue microarrays. Membranous IGF1R staining was evaluated using immunohistochemistry. A scoring method analogous to that of HER2 expression in breast carcinoma was used, and the highest score was assigned in each tumor. IGF1R was considered overexpressed in cases with score ≥1. Results We found IGF1R overexpression in 62{\%} of invasive UC. IGF1R overexpression was associated with race (P =.04) and pT category (P =.03). Median follow-up was 29 months (range, 0.5-212). Progression rate was 60{\%}, and overall mortality and cancer-specific mortality rates were 69{\%} and 51{\%}, respectively. In invasive UC, IGF1R overexpression was significantly associated with overall mortality and cancer-specific mortality (Mantel Cox P =.0002 and P =.006, respectively). IGF1R overexpression was associated with increased hazard ratios (HRs) for overall mortality (HR = 2.63, P =.001) and cancer-specific mortality (HR = 2.45, P =.01), independently and after adjusting for clinicopathologic features and treatment modalities. Conclusion We found IGF1R overexpression in 62{\%} of bladder UC. More importantly, IGF1R overexpression was a significant predictor of overall mortality and cancer-specific mortality, suggesting its potential role as a prognosticator in UC of bladder.",
author = "Nilda Gonzalez-Roibon and Kim, {Jenny J.} and Faraj, {Sheila F.} and Alcides Chaux and Bezerra, {Stephania M.} and Enrico Munari and Carla Ellis and Rajni Sharma and Daniel Keizman and Bivalacqua, {Trinity J.} and Schoenberg, {Mark P.} and Mario Eisenberger and Michael Carducci and Netto, {George J.}",
year = "2014",
doi = "10.1016/j.urology.2014.01.028",
language = "English (US)",
volume = "83",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder

T2 - A retrospective study of patients treated using radical cystectomy

AU - Gonzalez-Roibon, Nilda

AU - Kim, Jenny J.

AU - Faraj, Sheila F.

AU - Chaux, Alcides

AU - Bezerra, Stephania M.

AU - Munari, Enrico

AU - Ellis, Carla

AU - Sharma, Rajni

AU - Keizman, Daniel

AU - Bivalacqua, Trinity J.

AU - Schoenberg, Mark P.

AU - Eisenberger, Mario

AU - Carducci, Michael

AU - Netto, George J.

PY - 2014

Y1 - 2014

N2 - Objective To assess the insulin-like growth factor-1 receptor (IGF1R) expression in urothelial carcinoma (UC) and its prognostic role in relation to clinicopathologic parameters. Methods A total of 100 cases of invasive UC were evaluated using tissue microarrays. Membranous IGF1R staining was evaluated using immunohistochemistry. A scoring method analogous to that of HER2 expression in breast carcinoma was used, and the highest score was assigned in each tumor. IGF1R was considered overexpressed in cases with score ≥1. Results We found IGF1R overexpression in 62% of invasive UC. IGF1R overexpression was associated with race (P =.04) and pT category (P =.03). Median follow-up was 29 months (range, 0.5-212). Progression rate was 60%, and overall mortality and cancer-specific mortality rates were 69% and 51%, respectively. In invasive UC, IGF1R overexpression was significantly associated with overall mortality and cancer-specific mortality (Mantel Cox P =.0002 and P =.006, respectively). IGF1R overexpression was associated with increased hazard ratios (HRs) for overall mortality (HR = 2.63, P =.001) and cancer-specific mortality (HR = 2.45, P =.01), independently and after adjusting for clinicopathologic features and treatment modalities. Conclusion We found IGF1R overexpression in 62% of bladder UC. More importantly, IGF1R overexpression was a significant predictor of overall mortality and cancer-specific mortality, suggesting its potential role as a prognosticator in UC of bladder.

AB - Objective To assess the insulin-like growth factor-1 receptor (IGF1R) expression in urothelial carcinoma (UC) and its prognostic role in relation to clinicopathologic parameters. Methods A total of 100 cases of invasive UC were evaluated using tissue microarrays. Membranous IGF1R staining was evaluated using immunohistochemistry. A scoring method analogous to that of HER2 expression in breast carcinoma was used, and the highest score was assigned in each tumor. IGF1R was considered overexpressed in cases with score ≥1. Results We found IGF1R overexpression in 62% of invasive UC. IGF1R overexpression was associated with race (P =.04) and pT category (P =.03). Median follow-up was 29 months (range, 0.5-212). Progression rate was 60%, and overall mortality and cancer-specific mortality rates were 69% and 51%, respectively. In invasive UC, IGF1R overexpression was significantly associated with overall mortality and cancer-specific mortality (Mantel Cox P =.0002 and P =.006, respectively). IGF1R overexpression was associated with increased hazard ratios (HRs) for overall mortality (HR = 2.63, P =.001) and cancer-specific mortality (HR = 2.45, P =.01), independently and after adjusting for clinicopathologic features and treatment modalities. Conclusion We found IGF1R overexpression in 62% of bladder UC. More importantly, IGF1R overexpression was a significant predictor of overall mortality and cancer-specific mortality, suggesting its potential role as a prognosticator in UC of bladder.

UR - http://www.scopus.com/inward/record.url?scp=84901604277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901604277&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2014.01.028

DO - 10.1016/j.urology.2014.01.028

M3 - Article

VL - 83

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -